Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,351.36
(
-0.78%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: 10nisman post# 2086

Tuesday, 05/04/2004 10:26:01 AM

Tuesday, May 04, 2004 10:26:01 AM

Post# of 257269
The trial that has started is the so-called “207” trial (#msg-2920654), the small, safety/PK study. The “209” and “208” trials, which are efficacy trials, will be more consequential from a news-flow standpoint.

>> although no PR from GENR. <<

GENR’s PR machine has flopped again. I think this is a temporary problem. (Just posted about this on Yahoo.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today